Redx Pharma previews plans for idiopathic pulmonary fibrosis

CMO Dr Jane Robertson shares a sneak peek into trial designs for assets in IPF and Crohn’s disease planned for 2023/2024.

Related Keywords

Jane Robertson , Redx Pharma , Centric Services For , Laboratory Equipment , Contract Research Services For Clinical Trial , Drug Processing Technology , Clinical Trial Database , Clinical Trials , Processing Technology , Centric Services , Alternate Site Clinical Trials , Research Services , Clinical Trial ,